Articles tagged ‘diabetes’

Up to 24,000 people with diabetes are dying each year from causes that could be avoided through better management of their condition, according to the first ever report on mortality from the National Diabetes Audit.¹

A replacement cap for all major insulin pens (Timesulin®) was unveiled recently at the FEND Conference in Lisbon, Portugal. The cap has a built-in timer, telling the user exactly how much time has passed since their last insulin injection.

New research, funded by Diabetes UK, aims to establish whether regular doses of medication derived from fish oil could be used to prevent the onset of some of the serious complications of diabetes. Dr Keith McCormick, podiatrist and lecturer at the University of Southampton, has been awarded a three-year Allied Health Professional Fellowship worth £197,112 to conduct an 18-month clinical trial as part of a larger study supported by the National Institute for Health Research (NIHR).

Diabetes UK-funded research shows that a dietary supplement of the synthetic derivative of vitamin B1 has the potential to prevent heart disease caused by diabetes.

November 14 was World Diabetes Day (WDD), a worldwide initiative to raise awareness and understanding of the global diabetes pandemic. To mark this event, Andrew Lansley, CBE MP, Secretary of State for Health was principal guest speaker at a meeting bringing together members of the diabetes community as part of a reception focusing on issues currently faced by patients, healthcare professionals, politicians and policy makers throughout the UK. To coincide with this reception, the Merlin Entertainments London Eye was illuminated blue, representing the WDD blue circle logo.

The number of people diagnosed with diabetes in the UK has increased by more than 150,000 to 2.8 million in the past year, warns leading health charity Diabetes UK.

The Second Pan Asian-Pacific ESC Symposium – Moving Towards a Global Approach to Cardiovascular Disease Management will be held on 27th November at three venues across China.

Results from the Action in Diabetes and Vascular Disease: preterAx and diamicroN-MR Controlled Evaluation (ADVANCE) study (1) show that, among patients with type 2 diabetes, those who have atrial fibrillation (AF) are at higher risk of death from any cause, cardiovascular death, major cerebrovascular events and heart failure compared to those without AF. The absolute benefit of lowering blood pressure is therefore greater among patients with both diabetes and AF.